Talks@AU | The Dawn of Digital Biology

​The convergence of computational science, biology, and chemistry is redefining how molecules are designed and industrial processes are optimized. In this Talks@AU session, Mr. Naveen Kulkarni, CEO of Quantumzyme, explores the transformative potential of in silico enzyme engineering.

​Discover how advances in computational biology, molecular modeling, quantum chemistry, and AI-driven simulations are enabling the rational design of biocatalysts that replace traditional metal-based catalysts. By predicting enzyme–substrate interactions and optimizing catalytic performance before laboratory experimentation, digital biology is reducing development timelines, minimizing trial-and-error, and enabling cleaner, more sustainable manufacturing pathways.

​Through real-world case insights, this session highlights how computation-first chemistry is driving measurable environmental benefits, improved process efficiency, and better product outcomes, marking a paradigm shift toward sustainable industrial innovation.